JPRN-UMIN000020861已完成未知
Multicenter Retrospective Cohort Study Evaluating the Safety and Efficacy of Regorafenib in Patients with Metastatic Colorectal Cancer; the HGCSG1401 Study - Multicenter Retrospective Cohort Study of Regorafenib; the HGCSG1401 Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
RR and disease control rate (DCR) were 1.3% and 29.6%, respectively. Median PFS and median survival time (MST) were 2.1 and 6.3 months.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active double cancers
研究者
相似试验
Unknown
3 期
A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor ThrombiCarcinoma, HepatocellularNCT03939845Shanghai Zhongshan Hospital180
尚未招募
3 期
Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRTRecurrent Nasopharyngeal CarcinomaNCT04215510Eye & ENT Hospital of Fudan University286
进行中（未招募）
3 期
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)NCT06211764Janssen Research & Development, LLC272
已完成
不适用
Multicenter Retrospective Study to Evaluate Docetaxel plus Ramucirumab after Combination Therapy with PD-1 Inhibitor and Chemotherapyin Advanced Non-Small Cell Lung Cancernon-small cell lung cancerJPRN-UMIN000042333Saitama Medical University International Medical Center288
Unknown
3 期
Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young WomenBreast CancerNCT00912548Korean Breast Cancer Study Group1,234